Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment

Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis

(2017) Francesco Ursini et al.   Scientific Reports

Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?

(2016) Jonas K Eriksson et al.   ANNALS OF THE RHEUMATIC DISEASES

Anti-platelet drugs attenuate the expansion of circulating CD14highCD16+monocytes under pro-inflammatory conditions

(2016) Kerry Layne et al.   CARDIOVASCULAR RESEARCH

Microvascular Dysfunction and Cognitive Impairment

(2016) T. Michael De Silva et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases

(2016) Alessia Faccini et al.   EUROPEAN HEART JOURNAL

Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin

(2016) Paul M Ridker   EUROPEAN HEART JOURNAL

Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension

(2016) Tomasz P. Mikolajczyk et al.   FASEB JOURNAL

Postocclusive Hyperemia Measured with Laser Doppler Flowmetry and Transcutaneous Oxygen Tension in the Diagnosis of Primary Raynaud’s Phenomenon: A Prospective, Controlled Study

(2016) Paweł Maga et al.   Biomed Research International

Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality

(2015) Nisha Nigil Haroon et al.   ANNALS OF INTERNAL MEDICINE

The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials

(2015) Gabriella Passacquale et al.   CARDIOVASCULAR RESEARCH

Monocyte trafficking across the vessel wall

(2015) Teresa Gerhardt et al.   CARDIOVASCULAR RESEARCH

Subclinical Atherosclerosis Is Not Accelerated in Patients with Ankylosing Spondylitis with Low Disease Activity: New Data and Metaanalysis of Published Studies

(2015) A. Arida et al.   JOURNAL OF RHEUMATOLOGY

Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus

(2015) T P Mikołajczyk et al.   LUPUS

Cardiovascular events in ankylosing spondylitis: An updated meta-analysis

(2015) Sylvain Mathieu et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Smoking and Cardiovascular Disease

(2014) Barbara Messner et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions

(2014) J. C. Mason et al.   EUROPEAN HEART JOURNAL

Endothelial Dysfunction and Hypertension

(2014) Ralf P. Brandes   HYPERTENSION

The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis--a randomized, placebo-controlled pilot trial

(2014) L.-S. Tam et al.   RHEUMATOLOGY

Depletion of B‐Cells With Rituximab Improves Endothelial Function and Reduces Inflammation Among Individuals With Rheumatoid Arthritis

(2014) Priscilla Y. Hsue et al.   Journal of the American Heart Association

Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis

(2013) Alper M van Sijl et al.   ANNALS OF THE RHEUMATIC DISEASES

Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand?

(2013) M Nikpour et al.   LUPUS

Validated methods for assessment of subclinical atherosclerosis in rheumatology

(2012) György Kerekes et al.   Nature Reviews Rheumatology

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

(2011) Paul M Ridker et al.   AMERICAN HEART JOURNAL

Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: A population-based study

(2011) Shelagh M. Szabo et al.   ARTHRITIS AND RHEUMATISM

Assessment of Subclinical Vascular Disease Associated with Ankylosing Spondylitis

(2011) N. BODNAR et al.   JOURNAL OF RHEUMATOLOGY

Non-invasive Assessment of Skin Microvascular Function in Humans: An Insight Into Methods

(2011) MATTHIEU ROUSTIT et al.   MICROCIRCULATION

Reactive oxygen species and endothelial function in diabetes

(2010) Zahra Fatehi-Hassanabad et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Spondyloarthropathies: An independent cardiovascular risk factor?

(2010) Sylvain Mathieu et al.   JOINT BONE SPINE

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

(2009) M J L Peters et al.   ANNALS OF THE RHEUMATIC DISEASES

Signs of Accelerated Preclinical Atherosclerosis in Patients with Ankylosing Spondylitis

(2009) M. J.L. PETERS et al.   JOURNAL OF RHEUMATOLOGY

Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor   blockade

(2008) I C van Eijk et al.   ANNALS OF THE RHEUMATIC DISEASES

Capillaroscopy

(2008) Maurizio Cutolo et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients

(2007) A Sulli et al.   ANNALS OF THE RHEUMATIC DISEASES